Praxis Precision Medicines, Inc.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders. Their approach involves translating insights from genetic epilepsies into treatments for a range of CNS conditions, including movement disorders and epilepsy. They achieve this through their proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, which target shared biological pathways in the brain.

Praxis has established a diversified portfolio of CNS therapies, with four clinical-stage product candidates. They are committed to bringing innovative medicines to patients with serious or life-threatening conditions and are actively conducting clinical trials to evaluate the safety and efficacy of their investigational therapies. Their mission is to make the impossible possible by advancing their portfolio of precision therapies, particularly for central nervous system disorders.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. They translate insights from genetic epilepsies to create innovative therapies for both rare and more prevalent neurological disorders using their proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™. Their goal is to improve patient lives by leveraging their understanding of shared biological targets and circuits in the brain to develop safe and effective therapies.

Praxis Precision Medicines promotes a culture of innovation and collaboration, driven by a shared commitment to improving patient lives. They attract talented scientists and researchers across various disciplines, fostering an environment where diverse perspectives and expertise come together to push the boundaries of precision medicine. The company's dedication to ethical practices and patient-centricity is paramount, evident in their transparent approach to clinical trials and their commitment to serving patient families and communities.

Praxis Precision Medicines is committed to fostering a diverse, equitable, and inclusive workplace that values the unique perspectives and experiences of all individuals. The company believes that a diverse workforce leads to better decision-making, innovation, and scientific breakthroughs. Praxis actively seeks to recruit and retain a diverse team of employees, including people from underrepresented groups, and promotes an inclusive environment where all employees feel respected, valued, and empowered to contribute their best work.